03a: Cholinergic Drugs Flashcards

1
Q

Parasympathetic preganglionic fiber releases (X) messenger to bind (Y) receptor at synapse.

A
X = ACh
Y = nicotinic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sympathetic preganglionic fiber releases (X) messenger to bind (Y) receptor at synapse.

A
X = ACh
Y = nicotinic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Parasympathetic post-gang fibers release (X) messenger to bind (Y) receptor on heart muscle.

A
X = ACh
Y = muscarinic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sympathetics oppose parasymp action on heart by releasing (X) messenger to bind (Y) receptor on (Z) cells.

A
X = NE
Y = beta1
Z = myocardium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sympathetics oppose parasymp action on GI tract by releasing (X) messenger to bind (Y) receptor on (Z) cells.

A
X = NE
Y = alpha2
Z = post-gang parasymp neuron (terminal)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Parasympathetic post-gang fibers release (X) messenger to bind (Y) receptor to increase GI motility.

A
X = ACh
Y = muscarinic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

(Symp/parasymp) responsible for pupil dilation, aka (X).

A

Symp;

X = mydriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Predominant tone tends to be (parasymp/symp). List the key exceptions.

A

Parasymp;

  1. Blood vessels
  2. Sweat glands
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

(Cholinergics/adrenergics) responsible for predominant tone of salivary glands.

A

Cholinergics (parasymp)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

(Cholinergics/adrenergics) responsible for predominant tone of blood vessels.

A

Adrenergics (symp)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

(Cholinergics/adrenergics) responsible for predominant tone of sweat glands.

A

Cholinergics (but sympathetic NS!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Iris radial muscle innervated by (symp/parasymp) and has (X) receptor.

A

Symp;

X = a1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

(Symp/parasymp) relaxes bronchiolar smooth muscle. And (Symp/parasymp) contracts it. Which receptors involved?

A

Symp (beta2);

Parasymp (muscarinic - M2, M3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nicotinic receptor is a(n) (X)-gated (transporter/channel/ATPase). It transports (Y).

A

X = ligand;
Ion channel;

Y = Na, K, Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

T/F: Nicotinic receptor is an excitatory receptor.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

List the agonists of the nicotinic receptor. Star the muscle relaxant(s).

A
  1. Nicotine
  2. ACh
  3. Carbamoylcholine
  4. Succinylcholine*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

List the antagonists of the nicotinic receptor. Star the muscle relaxant(s).

A
  1. Hexamethonium
  2. Tubocurarine*
  3. Atracurium*

(only have to know Tubocurarine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ACh (does/doesn’t) penetrate cell membranes because of its structure as a(n) (X).

A

Doesn’t;

X = quaternary amine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

ACh rapidly inactivated by (X) at which location(s)?

A

X = AChE (at synapse) and esterases (in blood)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

(X), like ACh, is a quaternary amine and activates both N and M receptors. What’s a key difference between ACh and this agonist?

A

X = carbamylcholine

It’s an esterase-resistant analog of ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

(X) is a nicotinic agonist that’s CNS-penetrating due to its structure as a(n) (Y).

A
X = nicotine
Y = tertiary amine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Acute nicotine toxicity typically occurs via (X) route in children and (Y) route in adults.

A
X = ingestion
Y = dermal contact (i.e. tobacco workers)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Acute nicotine toxicity: rapid onset of which symptoms initially?

A
  1. Abd pain, nausea, diarrhea
  2. Disturbed vision, confusion
  3. Weakness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

T/F: Acute nicotine toxicity manifests in the respective symptoms due to overstimulated parasymp.

A

False - stimulates both parasymp and symp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Acute nicotine toxicity: central stimulation, in severe poisoning, will present with which symptoms?
Convulsions, coma, respiratory arrest
26
Acute nicotine toxicity: in severe poisoning, (tremors/paralysis) occurs via which mechanism(s)?
Paralysis; 1. Na channel inactivation 2. Desensitization of nicotinic receptors
27
List the treatment methods for acute nicotine toxicity.
1. Activated charcoal (reduce GI absorption) 2. Benzos (control seizures) 3. IV fluids (increase/maintain BP) 4. Atropine (if needed for bradycardia)
28
NMJ (neuromuscular junction) blocking agents have which general goal of action? What might these be used for?
Block ACh action at NMJ 1. Tracheal intubation 2. Set fractures 3. Surgical muscle relaxant
29
Neuromuscular (NMJ) blocking agents can fall into which categories? State which type of inhibition is found in each.
1. Depolarizing (non-competitive) | 2. Non-depolarizing (competitive)
30
Tubocurarine is an example of (X) drug. What's its mechanism?
X = muscle relaxant (non-depolarizing neuromuscular blocker) Competitive inhibition of ACh binding to nicotinic receptors at skeletal muscle endplate
31
When approximately (X)% of tubocurarine is bound, it is effective in (stimulating/preventing) (Y). What would this look like clinically?
X = 70 Preventing; Y = ACh evoking muscle contraction Flaccid paralysis of all skeletal muscle
32
AChE inhibitors (assist/oppose) action of tubocurarine. How?When might these be used?
Opposes; increase endogenous ACh Post-surgically to speed recovery
33
Succinylcholine is an example of (X) drug. What's its mechanism?
X = muscle relaxant (depolarizing neuromuscular blocker) Bind nicotinic receptor (AGONIST) and evokes desensitization
34
T/F: Effect of Succinylcholine cannot be reversed without synapse regeneration.
False - desensitized receptor can gradually reset (quick recovery) once agonist dissociates
35
T/F: Succinylcholine is esterase-resistant.
False - rapidly hydrolyzed by plasma cholinesterase
36
AChE inhibitors (assist/oppose) action of Succinylcholine. How?
Assist; | Increase endogenous ACh and further desensitize nicotinic receptors
37
List the stages of block by neuromuscular depolarizing agents, such as (X).
X = Succinylcholine 1. Fasciculation 2. Phase I (depolarizing) 3. Phase II (desensitizing)
38
T/F: Block by neuromuscular depolarizing agents prevents muscle from repolarizing at all.
False - in Phase II, muscle repolarizes (channels are closed), but continues to exhibit flaccid paralysis
39
Toxicity of nondepolarizing neuromuscular blocking agents, such as (X) involves:
X = tubocurarine Histamine release (allergic rxn)
40
Toxicity of depolarizing neuromuscular blocking agents, such as (X) involves:
X = succinylcholine 1. Malignant hyperthermia 2. Hyperkalemia 3. Cardiac dysrhythmias 4. Post-op muscle pain
41
Malignant hyperthermia can be the result of a toxic dose of (X). This is prolonged in patients with (low/high) levels of which enzyme?
X = succinylcholine Low; plasma cholinesterase
42
(Low/high) levels of which ion are responsible for malignant hyperthermia?
High; Ca
43
Toxicity via (X) neuromuscular blocking agent can result in (hyper/hypo)-kalemia via which mechanism?
X = succinylcholine Hyperkalemia; Excess K release through nicotinic receptor channels
44
(X) falls into the class of denervating neurotoxins. It binds specifically to (Y) terminals.
``` X = botulinum toxin Y = cholinergic nerve ```
45
T/F: Botulinum toxin has prolonged action (months).
True
46
T/F: Nerve terminals can recover within minutes to hours of removal of botulinum toxin.
False - only via axonal sprouting
47
List some adverse effects of botulinum toxin.
1. Muscle weakness (potentially long-lasting) | 2. Paralysis of respiratory muscles (can result in death)
48
T/F: Although botulinum toxin has been FDA approved for certain uses, a 2008 FDA warning was issued for some cases of resp failure/death.
True
49
T/F: there is no treatment for toxicity by botulism.
False - antitoxin exists (but doesn't reverse toxicity in nerve terminal)
50
Muscarinic receptor is a(n) (X) (transporter/channel/ATPase).
X = GPCR
51
List the subtypes of muscarinic receptors and the respective 2nd messenger pathways associated with each.
1. M1, 3, 5: Increase PLC activity (and thus DAG, IP3) | 2. M2, 4: Decrease cAMP (thus increase K and decrease Ca channel activation)
52
List the muscarinic receptor agonists and star those that also bind nicotinic receptors (non-selective).
1. ACh* 2. Carbamoylcholine* 3. Muscarine 4. Pilocarpine 5. Bethanchol (don't need to know)
53
List the clinical uses of ACh.
NONE! No clinical use
54
Pilocarpine is a(n) (X) class drug with some selectivity for (Y) tissues/organs. How is it used clinically?
``` X = muscarinic agonist (parasympathomimetic) Y = salivary glands ``` 1. Orally (treat xerostomia) 2. Topically (treat glaucoma)
55
List clinical presentation of muscarinic agonist toxicity.
1. Salivation 2. Lacrimation 3. Urination 4. Diarrhea 5. GI distress 6. Emesis (vomiting) (Plus bronchoconstriction, hypothension, bradycardia)
56
Belladonna alkaloids are (X) agents/drugs. List some examples.
X = anti-muscarinic 1. Atropine 2. Scopolamine
57
Anti-muscarinic agent would be used to treat (diarrhea/constipation) and (under/over)-active bladder.
Diarrhea; over-active
58
Muscarinic (agonist/antagonist) used to reduce HR, by preventing vagal stimulation, during MI.
Antagonist
59
Muscarinic (agonist/antagonist) used to treat AChE inhibitor poisoning.
Antagonist
60
Clinical presentation of muscarinic antagonist toxicity.
1. Dry as a bone 2. Hot as a pistol 3. Red as a beet 4. Blind as a bat 5. Mad as a hatter
61
Treatment for patient presenting with muscarinic antagonist toxicity.
AChE inhibitor (physostigmine)
62
List some conditions for which AChE inhibitors can serve as treatment.
1. AD 2. Myasthenia Gravis 3. Post-surg paralytic ileus 4. Urinary bladder atony
63
List some conditions for which AChE inhibitors can serve as treatment.
1. AD 2. Myasthenia Gravis 3. Post-surg paralytic ileus 4. Urinary bladder atony
64
List the major classes of AChE inhibitors. What's the primary difference between them? Star the one used clinically.
1. Alcohols 2. Carbamate esters* 3. Organophosphates Duration of action
65
List the major classes of AChE inhibitors. What's the primary difference between them?
1. Alcohols 2. Carbamate esters 3. Organophosphates Duration of action
66
T/F: Alcohols are rapidly reversible competitive inhibitors of AChE.
True
67
MOA of carbamate esters: form (reversible/irreversible) (X) bond that lasts on the order of (sec/min/hours/days).
Reversible; X = covalent Hours (about 1-6)
68
MOA of organophosphates: form (reversible/irreversible) (X) bond that lasts on the order of (sec/min/hours/days).
Irreversible X = phosphate Forever...
69
MOA of organophosphates: form (reversible/irreversible) (X) bond that lasts on the order of (sec/min/hours/days).
Irreversible X = phosphate Forever...
70
Sarin (nerve gas) poisoning likely due to (X) class of compounds. How might the individual present, clinically?
X = organophosphates (AChE inhibitors) 1. SLUDGE (muscarinic toxicity) 2. Neuromuscular block 3. Resp failure 4. Confusion, coma, convulsions
71
Sarin (nerve gas) poisoning likely due to (X) class of compounds. How might the individual present, clinically?
X = organophosphates (AChE inhibitors) 1. SLUDGE (muscarinic toxicity) 2. Neuromuscular block 3. Resp failure 4. Confusion, coma, convulsions
72
AChE inhibitor overdose/toxicity typically treated with (X). What's the MOA?
X = Atropine Blocks action at muscarinic (NOT NICOTINIC) receptors
73
(X) is known as "cholinesterase regenerator" and is, in a way, better than atropine for treating (Y) toxicity. Why?
``` X = Pralidoxime Y = AChE inhibitor (organophosphates) ``` Affects N and M receptor responses by binding organophosphates and causing them to release AChE (restores its function)